Global Quetiapine Fumarate Sustained Release Tablets Market Growth (Status and Outlook) 2026-2032
The global Quetiapine Fumarate Sustained Release Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Quetiapine Fumarate Sustained Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Quetiapine Fumarate Sustained Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Quetiapine Fumarate Sustained Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Quetiapine Fumarate Sustained Release Tablets players cover Luye Pharma Limited, PHARMATHEN INVESTMENTS GROUP LIMITED, Seroquel, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Quetiapine Fumarate Sustained Release Tablets Industry Forecast? looks at past sales and reviews total world Quetiapine Fumarate Sustained Release Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Quetiapine Fumarate Sustained Release Tablets sales for 2026 through 2032. With Quetiapine Fumarate Sustained Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Quetiapine Fumarate Sustained Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Quetiapine Fumarate Sustained Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Quetiapine Fumarate Sustained Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Quetiapine Fumarate Sustained Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Quetiapine Fumarate Sustained Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Quetiapine Fumarate Sustained Release Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Quetiapine Fumarate Sustained Release Tablets market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Quetiapine Fumarate Sustained Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Quetiapine Fumarate Sustained Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Quetiapine Fumarate Sustained Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Quetiapine Fumarate Sustained Release Tablets players cover Luye Pharma Limited, PHARMATHEN INVESTMENTS GROUP LIMITED, Seroquel, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Quetiapine Fumarate Sustained Release Tablets Industry Forecast? looks at past sales and reviews total world Quetiapine Fumarate Sustained Release Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Quetiapine Fumarate Sustained Release Tablets sales for 2026 through 2032. With Quetiapine Fumarate Sustained Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Quetiapine Fumarate Sustained Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Quetiapine Fumarate Sustained Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Quetiapine Fumarate Sustained Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Quetiapine Fumarate Sustained Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Quetiapine Fumarate Sustained Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Quetiapine Fumarate Sustained Release Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Quetiapine Fumarate Sustained Release Tablets market by product type, application, key players and key regions and countries.
Segmentation by Type:
- 50mg
- 200mg
- 300mg
- 400mg
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Luye Pharma Limited
- PHARMATHEN INVESTMENTS GROUP LIMITED
- Seroquel
- Teva Pharmaceutical Industries
- Dr. Reddy's Laboratories
- Sun Pharmaceutical Industries
- Mylan N.V.
- Torrent Pharmaceuticals
- Lupin Limited
- Sandoz
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size (2021-2032)
2.1.2 Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Quetiapine Fumarate Sustained Release Tablets by Country/Region (2021, 2025 & 2032)
2.2 Quetiapine Fumarate Sustained Release Tablets Segment by Type
2.2.1 50mg
2.2.2 200mg
2.2.3 300mg
2.2.4 400mg
2.2.5 Quetiapine Fumarate Sustained Release Tablets Market Size by Type
2.2.5.1 Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
2.3 Quetiapine Fumarate Sustained Release Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Quetiapine Fumarate Sustained Release Tablets Market Size by Application
2.3.4.1 Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
3 QUETIAPINE FUMARATE SUSTAINED RELEASE TABLETS MARKET SIZE BY PLAYER
3.1 Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Player
3.1.1 Global Quetiapine Fumarate Sustained Release Tablets Revenue by Player (2021-2026)
3.1.2 Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Player (2021-2026)
3.2 Global Quetiapine Fumarate Sustained Release Tablets Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 QUETIAPINE FUMARATE SUSTAINED RELEASE TABLETS BY REGION
4.1 Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026)
4.2 Global Quetiapine Fumarate Sustained Release Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Quetiapine Fumarate Sustained Release Tablets Market Size Growth (2021-2026)
4.4 APAC Quetiapine Fumarate Sustained Release Tablets Market Size Growth (2021-2026)
4.5 Europe Quetiapine Fumarate Sustained Release Tablets Market Size Growth (2021-2026)
4.6 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026)
5.2 Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026)
5.3 Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026)
6.2 APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026)
6.3 APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026)
7.2 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026)
7.3 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets by Region (2021-2026)
8.2 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026)
8.3 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL QUETIAPINE FUMARATE SUSTAINED RELEASE TABLETS MARKET FORECAST
10.1 Global Quetiapine Fumarate Sustained Release Tablets Forecast by Region (2027-2032)
10.1.1 Global Quetiapine Fumarate Sustained Release Tablets Forecast by Region (2027-2032)
10.1.2 Americas Quetiapine Fumarate Sustained Release Tablets Forecast
10.1.3 APAC Quetiapine Fumarate Sustained Release Tablets Forecast
10.1.4 Europe Quetiapine Fumarate Sustained Release Tablets Forecast
10.1.5 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Forecast
10.2 Americas Quetiapine Fumarate Sustained Release Tablets Forecast by Country (2027-2032)
10.2.1 United States Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.2.2 Canada Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.2.3 Mexico Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.2.4 Brazil Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.3 APAC Quetiapine Fumarate Sustained Release Tablets Forecast by Region (2027-2032)
10.3.1 China Quetiapine Fumarate Sustained Release Tablets Market Forecast
10.3.2 Japan Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.3.3 Korea Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.3.4 Southeast Asia Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.3.5 India Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.3.6 Australia Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.4 Europe Quetiapine Fumarate Sustained Release Tablets Forecast by Country (2027-2032)
10.4.1 Germany Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.4.2 France Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.4.3 UK Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.4.4 Italy Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.4.5 Russia Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.5 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Forecast by Region (2027-2032)
10.5.1 Egypt Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.5.2 South Africa Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.5.3 Israel Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.5.4 Turkey Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.6 Global Quetiapine Fumarate Sustained Release Tablets Forecast by Type (2027-2032)
10.7 Global Quetiapine Fumarate Sustained Release Tablets Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Quetiapine Fumarate Sustained Release Tablets Forecast
11 KEY PLAYERS ANALYSIS
11.1 Luye Pharma Limited
11.1.1 Luye Pharma Limited Company Information
11.1.2 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product Offered
11.1.3 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Luye Pharma Limited Main Business Overview
11.1.5 Luye Pharma Limited Latest Developments
11.2 PHARMATHEN INVESTMENTS GROUP LIMITED
11.2.1 PHARMATHEN INVESTMENTS GROUP LIMITED Company Information
11.2.2 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product Offered
11.2.3 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 PHARMATHEN INVESTMENTS GROUP LIMITED Main Business Overview
11.2.5 PHARMATHEN INVESTMENTS GROUP LIMITED Latest Developments
11.3 Seroquel
11.3.1 Seroquel Company Information
11.3.2 Seroquel Quetiapine Fumarate Sustained Release Tablets Product Offered
11.3.3 Seroquel Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Seroquel Main Business Overview
11.3.5 Seroquel Latest Developments
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Information
11.4.2 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Offered
11.4.3 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Teva Pharmaceutical Industries Main Business Overview
11.4.5 Teva Pharmaceutical Industries Latest Developments
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Company Information
11.5.2 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product Offered
11.5.3 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Dr. Reddy's Laboratories Main Business Overview
11.5.5 Dr. Reddy's Laboratories Latest Developments
11.6 Sun Pharmaceutical Industries
11.6.1 Sun Pharmaceutical Industries Company Information
11.6.2 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Offered
11.6.3 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Sun Pharmaceutical Industries Main Business Overview
11.6.5 Sun Pharmaceutical Industries Latest Developments
11.7 Mylan N.V.
11.7.1 Mylan N.V. Company Information
11.7.2 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product Offered
11.7.3 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Mylan N.V. Main Business Overview
11.7.5 Mylan N.V. Latest Developments
11.8 Torrent Pharmaceuticals
11.8.1 Torrent Pharmaceuticals Company Information
11.8.2 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product Offered
11.8.3 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Torrent Pharmaceuticals Main Business Overview
11.8.5 Torrent Pharmaceuticals Latest Developments
11.9 Lupin Limited
11.9.1 Lupin Limited Company Information
11.9.2 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product Offered
11.9.3 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Lupin Limited Main Business Overview
11.9.5 Lupin Limited Latest Developments
11.10 Sandoz
11.10.1 Sandoz Company Information
11.10.2 Sandoz Quetiapine Fumarate Sustained Release Tablets Product Offered
11.10.3 Sandoz Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Sandoz Main Business Overview
11.10.5 Sandoz Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size (2021-2032)
2.1.2 Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Quetiapine Fumarate Sustained Release Tablets by Country/Region (2021, 2025 & 2032)
2.2 Quetiapine Fumarate Sustained Release Tablets Segment by Type
2.2.1 50mg
2.2.2 200mg
2.2.3 300mg
2.2.4 400mg
2.2.5 Quetiapine Fumarate Sustained Release Tablets Market Size by Type
2.2.5.1 Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
2.3 Quetiapine Fumarate Sustained Release Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Quetiapine Fumarate Sustained Release Tablets Market Size by Application
2.3.4.1 Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
3 QUETIAPINE FUMARATE SUSTAINED RELEASE TABLETS MARKET SIZE BY PLAYER
3.1 Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Player
3.1.1 Global Quetiapine Fumarate Sustained Release Tablets Revenue by Player (2021-2026)
3.1.2 Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Player (2021-2026)
3.2 Global Quetiapine Fumarate Sustained Release Tablets Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 QUETIAPINE FUMARATE SUSTAINED RELEASE TABLETS BY REGION
4.1 Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026)
4.2 Global Quetiapine Fumarate Sustained Release Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Quetiapine Fumarate Sustained Release Tablets Market Size Growth (2021-2026)
4.4 APAC Quetiapine Fumarate Sustained Release Tablets Market Size Growth (2021-2026)
4.5 Europe Quetiapine Fumarate Sustained Release Tablets Market Size Growth (2021-2026)
4.6 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026)
5.2 Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026)
5.3 Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026)
6.2 APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026)
6.3 APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026)
7.2 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026)
7.3 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets by Region (2021-2026)
8.2 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026)
8.3 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL QUETIAPINE FUMARATE SUSTAINED RELEASE TABLETS MARKET FORECAST
10.1 Global Quetiapine Fumarate Sustained Release Tablets Forecast by Region (2027-2032)
10.1.1 Global Quetiapine Fumarate Sustained Release Tablets Forecast by Region (2027-2032)
10.1.2 Americas Quetiapine Fumarate Sustained Release Tablets Forecast
10.1.3 APAC Quetiapine Fumarate Sustained Release Tablets Forecast
10.1.4 Europe Quetiapine Fumarate Sustained Release Tablets Forecast
10.1.5 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Forecast
10.2 Americas Quetiapine Fumarate Sustained Release Tablets Forecast by Country (2027-2032)
10.2.1 United States Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.2.2 Canada Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.2.3 Mexico Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.2.4 Brazil Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.3 APAC Quetiapine Fumarate Sustained Release Tablets Forecast by Region (2027-2032)
10.3.1 China Quetiapine Fumarate Sustained Release Tablets Market Forecast
10.3.2 Japan Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.3.3 Korea Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.3.4 Southeast Asia Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.3.5 India Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.3.6 Australia Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.4 Europe Quetiapine Fumarate Sustained Release Tablets Forecast by Country (2027-2032)
10.4.1 Germany Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.4.2 France Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.4.3 UK Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.4.4 Italy Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.4.5 Russia Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.5 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Forecast by Region (2027-2032)
10.5.1 Egypt Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.5.2 South Africa Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.5.3 Israel Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.5.4 Turkey Market Quetiapine Fumarate Sustained Release Tablets Forecast
10.6 Global Quetiapine Fumarate Sustained Release Tablets Forecast by Type (2027-2032)
10.7 Global Quetiapine Fumarate Sustained Release Tablets Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Quetiapine Fumarate Sustained Release Tablets Forecast
11 KEY PLAYERS ANALYSIS
11.1 Luye Pharma Limited
11.1.1 Luye Pharma Limited Company Information
11.1.2 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product Offered
11.1.3 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Luye Pharma Limited Main Business Overview
11.1.5 Luye Pharma Limited Latest Developments
11.2 PHARMATHEN INVESTMENTS GROUP LIMITED
11.2.1 PHARMATHEN INVESTMENTS GROUP LIMITED Company Information
11.2.2 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product Offered
11.2.3 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 PHARMATHEN INVESTMENTS GROUP LIMITED Main Business Overview
11.2.5 PHARMATHEN INVESTMENTS GROUP LIMITED Latest Developments
11.3 Seroquel
11.3.1 Seroquel Company Information
11.3.2 Seroquel Quetiapine Fumarate Sustained Release Tablets Product Offered
11.3.3 Seroquel Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Seroquel Main Business Overview
11.3.5 Seroquel Latest Developments
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Information
11.4.2 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Offered
11.4.3 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Teva Pharmaceutical Industries Main Business Overview
11.4.5 Teva Pharmaceutical Industries Latest Developments
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Company Information
11.5.2 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product Offered
11.5.3 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Dr. Reddy's Laboratories Main Business Overview
11.5.5 Dr. Reddy's Laboratories Latest Developments
11.6 Sun Pharmaceutical Industries
11.6.1 Sun Pharmaceutical Industries Company Information
11.6.2 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Offered
11.6.3 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Sun Pharmaceutical Industries Main Business Overview
11.6.5 Sun Pharmaceutical Industries Latest Developments
11.7 Mylan N.V.
11.7.1 Mylan N.V. Company Information
11.7.2 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product Offered
11.7.3 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Mylan N.V. Main Business Overview
11.7.5 Mylan N.V. Latest Developments
11.8 Torrent Pharmaceuticals
11.8.1 Torrent Pharmaceuticals Company Information
11.8.2 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product Offered
11.8.3 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Torrent Pharmaceuticals Main Business Overview
11.8.5 Torrent Pharmaceuticals Latest Developments
11.9 Lupin Limited
11.9.1 Lupin Limited Company Information
11.9.2 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product Offered
11.9.3 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Lupin Limited Main Business Overview
11.9.5 Lupin Limited Latest Developments
11.10 Sandoz
11.10.1 Sandoz Company Information
11.10.2 Sandoz Quetiapine Fumarate Sustained Release Tablets Product Offered
11.10.3 Sandoz Quetiapine Fumarate Sustained Release Tablets Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Sandoz Main Business Overview
11.10.5 Sandoz Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Quetiapine Fumarate Sustained Release Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 200mg
Table 5. Major Players of 300mg
Table 6. Major Players of 400mg
Table 7. Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
Table 10. Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
Table 13. Global Quetiapine Fumarate Sustained Release Tablets Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Player (2021-2026)
Table 15. Quetiapine Fumarate Sustained Release Tablets Key Players Head office and Products Offered
Table 16. Quetiapine Fumarate Sustained Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Region (2021-2026)
Table 21. Global Quetiapine Fumarate Sustained Release Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Country (2021-2026)
Table 25. Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
Table 27. Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
Table 29. APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Region (2021-2026)
Table 31. APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Country (2021-2026)
Table 35. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Quetiapine Fumarate Sustained Release Tablets
Table 41. Key Market Challenges & Risks of Quetiapine Fumarate Sustained Release Tablets
Table 42. Key Industry Trends of Quetiapine Fumarate Sustained Release Tablets
Table 43. Global Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Luye Pharma Limited Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 48. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 49. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Luye Pharma Limited Main Business
Table 51. Luye Pharma Limited Latest Developments
Table 52. PHARMATHEN INVESTMENTS GROUP LIMITED Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 53. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 54. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. PHARMATHEN INVESTMENTS GROUP LIMITED Main Business
Table 56. PHARMATHEN INVESTMENTS GROUP LIMITED Latest Developments
Table 57. Seroquel Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 58. Seroquel Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 59. Seroquel Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Seroquel Main Business
Table 61. Seroquel Latest Developments
Table 62. Teva Pharmaceutical Industries Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 63. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 64. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Teva Pharmaceutical Industries Main Business
Table 66. Teva Pharmaceutical Industries Latest Developments
Table 67. Dr. Reddy's Laboratories Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 68. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 69. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Dr. Reddy's Laboratories Main Business
Table 71. Dr. Reddy's Laboratories Latest Developments
Table 72. Sun Pharmaceutical Industries Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 73. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 74. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Sun Pharmaceutical Industries Main Business
Table 76. Sun Pharmaceutical Industries Latest Developments
Table 77. Mylan N.V. Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 78. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 79. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Mylan N.V. Main Business
Table 81. Mylan N.V. Latest Developments
Table 82. Torrent Pharmaceuticals Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 83. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 84. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Torrent Pharmaceuticals Main Business
Table 86. Torrent Pharmaceuticals Latest Developments
Table 87. Lupin Limited Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 88. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 89. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Lupin Limited Main Business
Table 91. Lupin Limited Latest Developments
Table 92. Sandoz Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 93. Sandoz Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 94. Sandoz Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Sandoz Main Business
Table 96. Sandoz Latest Developments
Table 1. Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Quetiapine Fumarate Sustained Release Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 200mg
Table 5. Major Players of 300mg
Table 6. Major Players of 400mg
Table 7. Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
Table 10. Quetiapine Fumarate Sustained Release Tablets Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
Table 13. Global Quetiapine Fumarate Sustained Release Tablets Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Player (2021-2026)
Table 15. Quetiapine Fumarate Sustained Release Tablets Key Players Head office and Products Offered
Table 16. Quetiapine Fumarate Sustained Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Region (2021-2026)
Table 21. Global Quetiapine Fumarate Sustained Release Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Country (2021-2026)
Table 25. Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
Table 27. Americas Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
Table 29. APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Region (2021-2026)
Table 31. APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Country (2021-2026)
Table 35. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Quetiapine Fumarate Sustained Release Tablets
Table 41. Key Market Challenges & Risks of Quetiapine Fumarate Sustained Release Tablets
Table 42. Key Industry Trends of Quetiapine Fumarate Sustained Release Tablets
Table 43. Global Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Quetiapine Fumarate Sustained Release Tablets Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Luye Pharma Limited Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 48. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 49. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Luye Pharma Limited Main Business
Table 51. Luye Pharma Limited Latest Developments
Table 52. PHARMATHEN INVESTMENTS GROUP LIMITED Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 53. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 54. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. PHARMATHEN INVESTMENTS GROUP LIMITED Main Business
Table 56. PHARMATHEN INVESTMENTS GROUP LIMITED Latest Developments
Table 57. Seroquel Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 58. Seroquel Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 59. Seroquel Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Seroquel Main Business
Table 61. Seroquel Latest Developments
Table 62. Teva Pharmaceutical Industries Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 63. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 64. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Teva Pharmaceutical Industries Main Business
Table 66. Teva Pharmaceutical Industries Latest Developments
Table 67. Dr. Reddy's Laboratories Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 68. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 69. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Dr. Reddy's Laboratories Main Business
Table 71. Dr. Reddy's Laboratories Latest Developments
Table 72. Sun Pharmaceutical Industries Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 73. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 74. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Sun Pharmaceutical Industries Main Business
Table 76. Sun Pharmaceutical Industries Latest Developments
Table 77. Mylan N.V. Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 78. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 79. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Mylan N.V. Main Business
Table 81. Mylan N.V. Latest Developments
Table 82. Torrent Pharmaceuticals Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 83. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 84. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Torrent Pharmaceuticals Main Business
Table 86. Torrent Pharmaceuticals Latest Developments
Table 87. Lupin Limited Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 88. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 89. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Lupin Limited Main Business
Table 91. Lupin Limited Latest Developments
Table 92. Sandoz Details, Company Type, Quetiapine Fumarate Sustained Release Tablets Area Served and Its Competitors
Table 93. Sandoz Quetiapine Fumarate Sustained Release Tablets Product Offered
Table 94. Sandoz Quetiapine Fumarate Sustained Release Tablets Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Sandoz Main Business
Table 96. Sandoz Latest Developments
LIST OF FIGURES
Figure 1. Quetiapine Fumarate Sustained Release Tablets Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Quetiapine Fumarate Sustained Release Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Quetiapine Fumarate Sustained Release Tablets Sales Market Share by Country/Region (2025)
Figure 8. Quetiapine Fumarate Sustained Release Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type in 2025
Figure 10. Quetiapine Fumarate Sustained Release Tablets in Hospital
Figure 11. Global Quetiapine Fumarate Sustained Release Tablets Market: Hospital (2021-2026) & ($ millions)
Figure 12. Quetiapine Fumarate Sustained Release Tablets in Clinic
Figure 13. Global Quetiapine Fumarate Sustained Release Tablets Market: Clinic (2021-2026) & ($ millions)
Figure 14. Quetiapine Fumarate Sustained Release Tablets in Others
Figure 15. Global Quetiapine Fumarate Sustained Release Tablets Market: Others (2021-2026) & ($ millions)
Figure 16. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application in 2025
Figure 17. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Player in 2025
Figure 18. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Region (2021-2026)
Figure 19. Americas Quetiapine Fumarate Sustained Release Tablets Market Size 2021-2026 ($ millions)
Figure 20. APAC Quetiapine Fumarate Sustained Release Tablets Market Size 2021-2026 ($ millions)
Figure 21. Europe Quetiapine Fumarate Sustained Release Tablets Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size 2021-2026 ($ millions)
Figure 23. Americas Quetiapine Fumarate Sustained Release Tablets Value Market Share by Country in 2025
Figure 24. United States Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Region in 2025
Figure 29. APAC Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
Figure 30. APAC Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
Figure 31. China Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 35. India Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Country in 2025
Figure 38. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
Figure 39. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
Figure 40. Germany Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 41. France Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 54. APAC Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 55. Europe Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 57. United States Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 58. Canada Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 59. Mexico Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 60. Brazil Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 61. China Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 62. Japan Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 63. Korea Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 65. India Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 66. Australia Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 67. Germany Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 68. France Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 69. UK Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 70. Italy Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 71. Russia Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 72. Egypt Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 73. South Africa Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 74. Israel Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 75. Turkey Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 76. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 1. Quetiapine Fumarate Sustained Release Tablets Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Quetiapine Fumarate Sustained Release Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Quetiapine Fumarate Sustained Release Tablets Sales Market Share by Country/Region (2025)
Figure 8. Quetiapine Fumarate Sustained Release Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type in 2025
Figure 10. Quetiapine Fumarate Sustained Release Tablets in Hospital
Figure 11. Global Quetiapine Fumarate Sustained Release Tablets Market: Hospital (2021-2026) & ($ millions)
Figure 12. Quetiapine Fumarate Sustained Release Tablets in Clinic
Figure 13. Global Quetiapine Fumarate Sustained Release Tablets Market: Clinic (2021-2026) & ($ millions)
Figure 14. Quetiapine Fumarate Sustained Release Tablets in Others
Figure 15. Global Quetiapine Fumarate Sustained Release Tablets Market: Others (2021-2026) & ($ millions)
Figure 16. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application in 2025
Figure 17. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Player in 2025
Figure 18. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Region (2021-2026)
Figure 19. Americas Quetiapine Fumarate Sustained Release Tablets Market Size 2021-2026 ($ millions)
Figure 20. APAC Quetiapine Fumarate Sustained Release Tablets Market Size 2021-2026 ($ millions)
Figure 21. Europe Quetiapine Fumarate Sustained Release Tablets Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size 2021-2026 ($ millions)
Figure 23. Americas Quetiapine Fumarate Sustained Release Tablets Value Market Share by Country in 2025
Figure 24. United States Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Region in 2025
Figure 29. APAC Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
Figure 30. APAC Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
Figure 31. China Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 35. India Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Country in 2025
Figure 38. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
Figure 39. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
Figure 40. Germany Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 41. France Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Quetiapine Fumarate Sustained Release Tablets Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 54. APAC Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 55. Europe Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 57. United States Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 58. Canada Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 59. Mexico Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 60. Brazil Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 61. China Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 62. Japan Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 63. Korea Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 65. India Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 66. Australia Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 67. Germany Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 68. France Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 69. UK Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 70. Italy Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 71. Russia Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 72. Egypt Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 73. South Africa Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 74. Israel Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 75. Turkey Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
Figure 76. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Quetiapine Fumarate Sustained Release Tablets Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Quetiapine Fumarate Sustained Release Tablets Market Size 2027-2032 ($ millions)
